Delivered Q4 and FY2025 revenue above guidanceBest ARR performance of the year in Q4 with total ending ARR of $124 millionRecord percentage of ARR in multi-year agreements and record number of ...
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results